NYSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/21/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNYSE
Market Capitalization233.41 mln
Float0.80 mln
Earnings Date08/14/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-6.39
Highly reliable
Relative Strength
100
/ 100
Top performer
Debt / Equity
0.10
Very low leverage
ROE
-21.74
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
China Pharma Holdings Inc. is a Chinese pharmaceutical company based in Haikou that develops, manufactures, and sells a wide range of medicines for human use across China. Its product portfolio covers treatments for conditions affecting the brain and nervous system, the heart and blood vessels, the digestive system, and the respiratory tract, offered in forms such as injections, tablets, capsules, and oral solutions. The company also produces vitamins, anti-nausea medications for cancer patients undergoing treatment, and general health and hygiene products including food supplements and sanitizers. It distributes its products to hospitals and retail pharmacies through regional pharmaceutical distribution networks.
